Start with your question. Search first, choose the closest subject and keep personal details private. Posting guidelines
Notifications
Clear all
Topic starter
21/09/2022 4:11 am
Trying to separate three different claims about undecanoate: that it is the right molecule, that it is the right dose, and that it does something useful.
If you need three other compounds to notice the first one, you have not tested the first one.
The comparison group matters more than the compound when the outcome is something as fuzzy as focus.
Baseline first. Without a baseline the after picture is decoration.
Sample size, blinding, and who paid for it. Those three questions kill most of the confidence in most of these threads.
Estrogen management is overcorrected far more often than it is undercorrected.
Anyone got a paper worth reading on this rather than a write-up of a paper?